Ind-Swift Limited Market Cap ($9.23 Million)
Market Cap & Net Worth: Ind-Swift Limited (INDSWFTLTD)
Ind-Swift Limited market cap. Ind-Swift Limited (NSE:INDSWFTLTD) has a market capitalization of $9.23 Million (Rs853.64 Million) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #27139 globally and #1506 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ind-Swift Limited's stock price Rs15.76 by its total outstanding shares 54164700 (54.16 Million). Also see how efficiently does Ind-Swift Limited generate cash for how efficiently the company converts equity into cash flow.
Ind-Swift Limited Market Cap History (2015–2025)
Ind-Swift Limited market cap history from 2015 to 2025. Data shows growth from $3.43 Million to $9.23 Million (11.01% CAGR). Check Ind-Swift Limited (INDSWFTLTD) share price today for real-time trading data and today's change.
Ind-Swift Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ind-Swift Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Ind-Swift Limited to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Ind-Swift Limited's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Ind-Swift Limited's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.28 Million | $3.04 Billion | -$2.14 Billion | 0.00x | N/A |
| 2017 | $6.59 Million | $2.61 Billion | -$3.73 Billion | 0.00x | N/A |
| 2018 | $4.13 Million | $2.70 Billion | -$504.30 Million | 0.00x | N/A |
| 2019 | $1.79 Million | $2.87 Billion | $81.93 Million | 0.00x | 0.02x |
| 2020 | $2.26 Million | $3.30 Billion | -$191.21 Million | 0.00x | N/A |
| 2021 | $7.20 Million | $3.52 Billion | -$298.16 Million | 0.00x | N/A |
| 2022 | $7.41 Million | $3.91 Billion | -$200.20 Million | 0.00x | N/A |
| 2023 | $10.66 Million | $3.99 Billion | $260.37 Million | 0.00x | 0.04x |
| 2024 | $19.36 Million | $5.02 Billion | $142.31 Million | 0.00x | 0.14x |
| 2025 | $9.23 Million | $5.15 Billion | $2.83 Billion | 0.00x | 0.00x |
Competitor Companies of INDSWFTLTD by Market Capitalization
Companies near Ind-Swift Limited in the global market cap rankings as of November 4, 2026. Also see INDSWFTLTD total asset value for a full breakdown of the balance sheet.
Key companies related to Ind-Swift Limited by market ranking:
- Clinical Laserthermia Systems AB (publ) (ST:CLS-B): Ranked #27130 globally with a market cap of $9.27 Million USD ( Skr86.16 Million SEK).
- WALLBOX N.V. CL.A EO-12 (F:67E): Ranked #27131 globally with a market cap of $9.27 Million USD ( €7.93 Million EUR).
- EBANG INTL HLDGS (NEW) A (F:7EBA): Ranked #27140 globally with a market cap of $9.23 Million USD ( €7.89 Million EUR).
- South Malaysia Industries Bhd (KLSE:4375): Ranked #27141 globally with a market cap of $9.22 Million USD ( RM36.74 Million MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #27130 | Clinical Laserthermia Systems AB (publ) | ST:CLS-B | $9.27 Million | Skr1.78 |
| #27131 | WALLBOX N.V. CL.A EO-12 | F:67E | $9.27 Million | €4.91 |
| #27140 | EBANG INTL HLDGS (NEW) A | F:7EBA | $9.23 Million | €1.67 |
| #27141 | South Malaysia Industries Bhd | KLSE:4375 | $9.22 Million | RM0.18 |
Market Capitalization of Ind-Swift Limited (2015–2025)
Market capitalization of Ind-Swift Limited from 2015 to today. Between 2015 and today, Ind-Swift Limited's market cap moved from $3.43 Million to $ 9.23 Million, with a yearly change of 11.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Rs9.23 Million | -52.31% |
| 2024 | Rs19.36 Million | +81.59% |
| 2023 | Rs10.66 Million | +43.87% |
| 2022 | Rs7.41 Million | +2.85% |
| 2021 | Rs7.20 Million | +219.48% |
| 2020 | Rs2.26 Million | +26.23% |
| 2019 | Rs1.79 Million | -56.74% |
| 2018 | Rs4.13 Million | -37.33% |
| 2017 | Rs6.59 Million | +100.89% |
| 2016 | Rs3.28 Million | -4.27% |
| 2015 | Rs3.43 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 12th, 2026 the market cap of Ind-Swift Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.23 Million USD |
| MoneyControl | $9.23 Million USD |
| MarketWatch | $9.23 Million USD |
| marketcap.company | $9.23 Million USD |
| Reuters | $9.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ind-Swift Limited
Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin… Read more